Description
Alidya 5×10 is a CE-marked injectable medical device developed by Marllor Biomedical for the prevention and treatment of gynoid lipodystrophy, commonly known as cellulite. Unlike traditional fat-dissolving products, Alidya is designed to address several physiological factors associated with cellulite, including extracellular matrix imbalance, tissue oxygenation, microcirculation dysfunction, and oxidative stress.
The formulation consists of a polyamino acid complex supplied as a powder for reconstitution with a dedicated solvent. According to manufacturer and distributor information, Alidya aims to restore normal adipocyte homeostasis and improve the appearance of cellulite-related skin irregularities such as orange-peel texture and tissue dimpling. It is commonly used as part of mesotherapy-based cellulite management protocols for areas including the thighs, buttocks, abdomen, hips, and knees. Clinical protocols generally focus on improving skin texture and tissue quality rather than producing significant fat reduction.
What Alidya 5×10 Is Similar To
Alidya belongs to the category of injectable anti-cellulite and mesotherapy treatments. It is often compared with products such as Celluform®, Sunekos Cell®, and other mesotherapy formulations used for cellulite management and skin quality improvement.
Unlike deoxycholic acid-based fat dissolvers that primarily target adipocyte destruction, Alidya focuses on restoring extracellular tissue balance and supporting microcirculation. This distinction makes it more suitable for cellulite treatment rather than localized fat reduction.
Compared with regenerative mesotherapy products that primarily stimulate collagen production, Alidya specifically targets factors associated with cellulite development, including tissue oxygenation, extracellular matrix alterations, and adipose tissue homeostasis. Treatment goals are therefore generally focused on improving skin smoothness and reducing visible cellulite irregularities rather than body contouring alone.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer-aligned sources, Alidya may be used for:
- Thighs
- Buttocks
- Hips
- Abdomen
- Stomach
- Knees
- Upper arms
- Areas affected by gynoid lipodystrophy (cellulite)
Indications include:
- Grade I–III cellulite
- Orange-peel skin appearance
- Prevention of cellulite progression
- Improvement of cellulite-related skin irregularities
Usage / Administration (IFU-Only Section)
- Injection depth: Approximately 4–6 mm according to professional protocols referenced by distributors.
- Volume per injection point: Not provided by manufacturer in publicly accessible IFU documentation.
- Needle gauge: Not consistently specified in official documentation. Some professional protocols reference 30G needles.
- Treatment frequency: One treatment session per week.
- Number of sessions: Typically 7–12 weekly sessions depending on cellulite severity.
- Maximum volume per session: Up to 20 ml according to available professional guidance.
- Professional-use statement: Alidya should only be administered by qualified healthcare professionals using aseptic technique and in accordance with manufacturer instructions and local regulations.
Ingredient List
Active Components
- Polyamino acid complex
- D-(+) Alpha-D-glucopyranose
- Amino acid blend
Additional Components Reported by Distributors
- Sodium bicarbonate buffer
- Succinate buffer system
- Iron-chelating compounds
Hyaluronic Acid
- Not applicable.
Lidocaine
- No lidocaine reported in publicly available product documentation.
Presentation & Longevity
Packaging
- 5 × 340 mg powder vials
- 5 × 10 ml solvent vials
Product Format
- Injectable medical device supplied for reconstitution prior to administration.
Longevity
Manufacturer-aligned sources indicate that improvements are commonly maintained for approximately 12 months, after which maintenance treatment may be considered.
Results vary according to cellulite severity, patient characteristics, lifestyle factors, and treatment protocol.
Storage
- Store according to manufacturer instructions.
- Protect from excessive heat and freezing.
Safety Notes / Contraindications
- Contraindicated in patients with known hypersensitivity to any component of the formulation.
- Do not administer in areas with active infection, inflammation, or compromised skin integrity.
- Safety during pregnancy and breastfeeding has not been established.
- Treatment should only be performed by qualified healthcare professionals experienced in mesotherapy and injectable procedures.
As with other injectable treatments, temporary redness, swelling, tenderness, bruising, and injection-site discomfort may occur following treatment.
Regulatory Status
- Manufacturer: Marllor Biomedical (Italy)
- CE-Marked Medical Device
- Professional-use injectable product
UKCA status: Verify via current IFU, manufacturer documentation, or authorised distributor.
FDA status: No publicly available FDA approval identified for Alidya cellulite treatment.
Frequently Asked Questions
1. What is Alidya cellulite treatment?
Alidya is an injectable anti-cellulite medical device developed specifically for the prevention and treatment of gynoid lipodystrophy (cellulite). It is designed to improve tissue quality, support microcirculation, and reduce the visible appearance of cellulite-related skin irregularities such as dimpling and orange-peel texture.
2. How does Alidya work?
Unlike traditional fat-dissolving products, Alidya is intended to restore physiological balance within the extracellular matrix and adipose tissue environment. Manufacturer information indicates that the formulation supports tissue oxygenation, microcirculation, and adipocyte homeostasis while helping improve cellulite-related skin changes.
3. What treatment areas can be addressed with Alidya?
Alidya is commonly used on the thighs, buttocks, hips, abdomen, stomach, knees, and upper arms. These are among the areas most frequently affected by cellulite and associated tissue irregularities.
4. How many sessions are usually required?
Manufacturer-aligned protocols typically recommend one treatment session per week for a total of 7–12 sessions, depending on the severity of cellulite and practitioner assessment. Maintenance sessions may be performed after approximately one year when required.
5. What do Alidya cellulite reviews commonly mention?
Available professional feedback and published user discussions indicate that most interest in alidya cellulite reviews centres on improvements in skin texture, reduction of visible dimpling, and smoother skin appearance. Individual outcomes vary considerably depending on cellulite severity, treatment protocol, and lifestyle factors. Community discussions also note that evidence remains more limited than for some established aesthetic procedures.
